Ngaahi fakalelei'i 'o e Peptide

Pepitaiti FRET

FRET peptides study biological interactions in real time through energy transfer between donor fluorophores and acceptor bursters.

What is FRET peptide?

FRET peptide labelling has a donor molecule and an acceptor (bursting agent) molecule. In most cases, the donor and acceptor pairs are two different dyes. If the acceptor is a non-fluorescent dye (bursting agent), the transferred energy from the fluorescent donor is converted into molecular vibrations. When FRET is terminated (by separating the donor and acceptor), an increase in donor fluorescence can be detected. When both donor and acceptor dyes are fluorescent, the transferred energy is emitted as longer wavelength light, allowing changes in the donor and acceptor fluorescence intensity ratio to be measured. For efficient FRET bursting, the fluorophore and bursting agent molecules must be in close proximity to each other (~10-100 Å) and the absorption spectrum of the bursting agent must overlap with the emission spectrum of the fluorophore. Careful comparison of the fluorescence spectrum of the donor and the absorption spectrum of the bursting agent is required when designing donor-bursting agent FRET systems.

FRET peptides science

Key benefits of FRET peptides:

·Real-time monitoring of enzymatic reactions and protein activity.
·Extremely high detection sensitivity due to unique proximity-based energy transfer.
·Versatility for in vitro and in vivo applications, providing insight into complex biological processes.

Fluorophore
Quencher
Donor Ex/Em

Abz

Dnp 2,4-tainitolofenili

320 nm/420 nm

Abz

Dnp 2,4-tainitolofenili

320 nm/420 nm

Mca

Dnp 2,4-tainitolofenili

325 nm/392 nm

Trp

Dnp 2,4-tainitolofenili

280 nm/360 nm

FAM

Dabcyl4-([4'-dimethylamino)phenyl]azo)benzoyl

492 nm/517 nm

Lucifer Yellow

Dabsyl4(Dimethylamino)azobenzene-4'-sulfonyl

430nm/520nm

Ngaahi Lave Faka'ali'ali

Ultrasensitive tumour-penetrating nanosensors of protease activity

The ability to identify cancer lesions with endogenous biomarkers is currently limited to tumours ~1 cm in diameter. We recently reported an exogenously administered tumour-penetrating nanosensor that sheds, in response to tumour-specific proteases, peptide fragments that can then be detected in the urine. ʻi heni, we report the optimization, informed by a pharmacokinetic mathematical model, of the surface presentation of the peptide substrates to both enhance on-target protease cleavage and minimize off-target cleavage, and of the functionalization of the nanosensors with tumour-penetrating ligands that engage active trafficking pathways to increase activation in the tumour microenvironment. The resulting nanosensor discriminated sub-5 mm lesions in human epithelial tumours and detected nodules with median diameters smaller than 2 mm in an orthotopic model of ovarian cancer. We also demonstrate enhanced receptor-dependent specificity of signal generation in the urine in an immunocompetent model of colorectal liver metastases, and in situ activation of the nanosensors in human tumour microarrays when re-engineered as fluorogenic zymography probes.

Ngaahi Ngaue Fakalelei'i 'o e Peptide Fekau'aki

pepitaiti kalaikosaila

pepitaiti kalaikosaila

Ko e glycosylation 'o e peptide ko ha fakalelei'i 'o e covalent 'e lava ke malava ke fakalelei'i 'a e ngaahi 'ulungaanga fakatu'asino 'o e peptides .

Lau ha me'a lahi ange

peptide Fosifolila

peptide Fosifolila

'E lava ke hoko 'a e fosfola 'i he Serine . (S, Ke hoko), Teleonini (T, Thr) mo e Tailosini . (Y, Tyr) ngaahi seini tafa'aki 'e he fa'u 'o e fehokotaki'anga phosphoester

Lau ha me'a lahi ange

Peptides kuo fakapipiki

Peptides kuo fakapipiki

Fakafe'iloaki 'o e ongo 'esiti 'amino ta'efakanatula 'oku 'i ai 'a e α-methyl ., α-alkenyl ngaahi kulupu lolotonga 'a e synthesis 'o e konga fefeka 'o e ngaahi seini peptide ..

Lau ha me'a lahi ange

Pepitaiti Siakale

Pepitaiti Siakale

'Oku fakalahi 'e he siakale 'o e peptide 'a e tu'unga ma'u 'o e conformational 'o e peptides . ('o fakatatau ki he'enau ngaahi analogues fakalaine .) pea ko ha founga angamaheni ia 'i he fakalakalaka 'o e peptide ..

Lau ha me'a lahi ange

fakalelei'i 'o e peptide

A'usia lahi 'i he fakalelei'i 'o e peptide ., 'oatu 'a e ngaahi founga mo'ui lahi ki he fakatotolo peptide ..

Api Kumi Whatsapp Ngaahi Sevesi Koloa